ISPC
ISPC
NASDAQ · Health Care

Ispecimen Inc

$1.20
-0.01 (-0.83%)
As of Sep 29, 4:46 PM ET ·
Financial Highlights (FY 2026)
Revenue
41.56M
Net Income
-225,978,388
Gross Margin
1.2%
Profit Margin
-543.7%
Rev Growth
-43.0%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 1.2% 1.2% 46.6% 46.6%
Operating Margin -465.4% -418.9% 15.9% 13.1%
Profit Margin -543.7% -516.5% 10.7% 14.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 41.56M 72.88M 890.1K 703.7K
Gross Profit 519.6K 911.0K 415.1K 328.2K
Operating Income -193,451,292 -305,288,730 141.2K 92.5K
Net Income -225,978,388 -356,620,286 95.2K 101.7K
Gross Margin 1.2% 1.2% 46.6% 46.6%
Operating Margin -465.4% -418.9% 15.9% 13.1%
Profit Margin -543.7% -516.5% 10.7% 14.5%
Rev Growth -43.0% -43.0% +8.3% +9.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.46M 1.43M
Total Equity — — 1.24M 1.20M
D/E Ratio — — 1.18 1.19
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -191,974,924 -319,789,896 175.3K 162.6K
Free Cash Flow — — 124.9K 90.2K